What is Tesamorelin + Ipamorelin
What is Tesamorelin + Ipamorelin 13mg
Global Peptide Sciences supplies Tesamorelin + Ipamorelin 13mg in Australia as a fixed-ratio dual-peptide blend for controlled laboratory research. Each vial contains 10mg of tesamorelin and 3mg of ipamorelin in a lyophilised powder format.
This formulation is intended for researchers examining two distinct growth hormone-related signalling pathways within the same experimental model. Tesamorelin is a synthetic growth hormone-releasing hormone analogue that interacts with growth hormone-releasing factor receptors. Ipamorelin is a pentapeptide growth hormone secretagogue studied for its interaction with the ghrelin receptor, also known as the growth hormone secretagogue receptor.
The 10:3 composition provides a tesamorelin-weighted formulation while maintaining a defined ipamorelin component. This makes the blend relevant to laboratory investigations involving receptor-specific signalling, combined secretagogue models and downstream endocrine markers.
Researchers looking to buy research peptides online in Australia can order through Global Peptide Sciences with secure checkout, fast nationwide dispatch and batch-specific product documentation.
What is Tesamorelin?
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone. It contains the 44-amino-acid sequence of human growth hormone-releasing factor with an additional structural modification at the N-terminal region.
In laboratory models, tesamorelin binds to and activates growth hormone-releasing factor receptors. Researchers use it when examining GHRH receptor activity, pulsatile growth hormone signalling and downstream markers associated with the GH and IGF-1 pathway.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue receptor agonist and ghrelin mimetic.
Research literature describes ipamorelin as selectively stimulating growth hormone release through its interaction with the ghrelin or GHSR receptor. It is studied in experimental models involving secretagogue activity, receptor selectivity and endocrine signalling.
Tesamorelin + Ipamorelin Research Applications
The Tesamorelin + Ipamorelin blend may be studied in controlled laboratory environments investigating:
- GHRH receptor and GHSR pathway interactions
- Combined growth hormone secretagogue signalling
- Pulsatile growth hormone release models
- Downstream GH and IGF-1 marker analysis
- Receptor-selective endocrine research
- Comparative single-peptide and dual-peptide models
- Dose-ratio and pathway-response characterisation
- Peptide stability and preparation studies
These applications refer only to laboratory and experimental research. They are not statements of therapeutic benefit.
Research Areas of Interest
- Growth hormone-releasing hormone pathway research
- Ghrelin receptor and GHSR signalling studies
- Pituitary and endocrine pathway investigations
- Dual-secretagogue experimental models
- GH pulse and downstream biomarker research
- Peptide interaction and receptor-response studies
- Fixed-ratio peptide blend characterisation
Why Researchers Choose Tesamorelin + Ipamorelin
Researchers may select Tesamorelin + Ipamorelin 13mg for its:
- Defined 10mg to 3mg peptide composition
- Tesamorelin-weighted fixed ratio
- Inclusion of two independently characterised receptor pathways
- Relevance to combined GHRH and GHSR signalling models
- Pre-measured lyophilised presentation
- Suitability for controlled concentration and ratio studies
- Batch-specific identification and documentation
Buy Tesamorelin + Ipamorelin 13mg in Australia
Global Peptide Sciences supplies Tesamorelin + Ipamorelin 13mg for laboratory and scientific research applications.
Researchers can securely buy research peptides online in Australia through our platform with:
- Batch-specific Certificate of Analysis documentation
- Secure online ordering
- Express dispatch from Perth
- Fast nationwide Australian shipping
- Clearly identified peptide composition
- Research-use labelling and handling information
All products supplied by Global Peptide Sciences are intended strictly for laboratory and scientific research.
Research Use Only
This formulation is supplied strictly for laboratory research and analytical use.
It is not intended for human or animal consumption and must not be used as a medicine, therapeutic product, supplement, food product or cosmetic.
Research Applications
Research Applications
Tesamorelin + Ipamorelin 13mg may be used as a laboratory research material to study:
- GHRH receptor activation and signalling
- Ghrelin receptor and GHSR pathway activity
- Combined secretagogue pathway models
- Growth hormone pulse-response patterns
- Downstream endocrine marker changes
- Receptor selectivity and pathway comparison
- Dose-asymmetric peptide blend models
- Peptide preparation, solubility and stability
Tesamorelin and ipamorelin act through different receptor systems. Tesamorelin interacts with the growth hormone-releasing factor receptor, while ipamorelin is characterised as a ghrelin receptor or GHSR agonist.
Previous Research Dosages Used
No universally accepted research dosage has been established for this fixed-ratio Tesamorelin + Ipamorelin blend.
Experimental quantities should be determined by qualified researchers according to:
- The selected in vitro or preclinical model
- Assay sensitivity
- Target concentration
- Study duration
- Research endpoints
- Institutional laboratory protocols
The vial contains a fixed total quantity of 13mg, comprising 10mg tesamorelin and 3mg ipamorelin.
Laboratory Preparation Reference
Vial Content:
13mg total peptide blend
Example Solvent Volume:
2mL
Resulting Total Concentration:
6.5mg/mL
Tesamorelin Concentration:
5mg/mL
Ipamorelin Concentration:
1.5mg/mL
This information is provided only as a laboratory concentration reference. It is not administration or consumption guidance.
Handling Notes
Allow the lyophilised vial and laboratory solvent to reach the temperature required by the validated research protocol before preparation.
Introduce the solvent slowly down the inside wall of the vial to reduce foaming and mechanical stress. Gently roll or swirl the vial until the material has dissolved.
Do not shake.
Use aseptic laboratory technique and a solvent appropriate to the intended analytical procedure.
Storage
Before Preparation:
Store at -20°C in a cool, dry environment protected from direct light and moisture.
After Preparation:
Store refrigerated at 2–8°C unless the validated laboratory protocol specifies otherwise.
Prepared-solution stability depends on the solvent, concentration, handling conditions and research procedure. Researchers should follow their own validated stability data when setting a usage period.
Certificate of Analysis
Chemical Structure
Purity≥99%
AppearanceWhite Lyophilized Powder
StorageStore at -20°C
FormLyophilized Powder
- Fixed 10:3 tesamorelin-to-ipamorelin mass ratio
- Contains a 44-amino-acid GHRH analogue
- Contains a pentapeptide GHSR agonist
- Combines two chemically distinct peptide components
- Does not have a single blend-specific CAS number
- Does not have a single molecular formula or molecular weight
- Presented as a pre-measured lyophilised research blend